Stock Ratings / Health Care / AZN / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

AstraZeneca PLC (AZN) 12-Month Stock Forecast & Price Target Cone

$174.40 +2.89% NYSE • Public Delayed / 60s Snapshot

AstraZeneca PLC (AZN) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.

ROARABLE C • HOLD / WATCH Cap $270.45B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+2.2% Base Target

WHALE OPTIONS TUG-OF-WAR:62% Call Buyers ($30.0M)

38% PutsMax Pain: $171.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your AZN Position Size: $10,000

Shares at $174.40: 57.3 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $139.09

$7,975

$-2,025 (-20.2%)

12M Consensus BaseTarget $178.32

$10,225

+$225 (+2.2%)

12M Bull Case BreakoutTarget $223.35

$12,807

+$2,807 (+28.1%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$185	74%	A
Goldman SachsSector Coverage Lead	BUY	$210	69%	B
JP MorganUS Large-Cap Research	HOLD	$159	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live AZN Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

AZN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -0.38%▲ RESISTANCE BREAKOUT

2026-10-30O $183.6H $188.4L $183.1C $186.7VOL 5.46M

RES: $165.2SUP: $154.2SMA50: $164.5SMA200: $180.2

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AZN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AZN Butterfly Map → + Track AZN →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

25.3%/yr Implied 5Y Growth

vs. +22.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AZN today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AZN. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for AZN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

AZN Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is AZN's 12-month stock price target?

AstraZeneca PLC (AZN) carries a 12-month consensus base price target of $178.32 (+2.2% from $174.40), with a bull-case target of $223.35 and a bear-case floor of $139.09.